Cupps Capital Management’s VivoSim Labs VIVS Stock Holding History

Cupps Capital Management’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-44	Closed	-$116K	–	221
2013 Q4	$116K	Buy	+44	New	+$86.4K	0.01%	147

Other funds holding VIVS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cupps Capital Management's VIVS Position: Q1 2014 in Review

Cupps Capital Management sold out of VivoSim Labs (VIVS) in Q1 2014, closing a stake of 44 shares — an estimated $116K sold.

Cupps Capital Management first reported a position in VIVS in Q4 2013 and held it in 1 quarter. The position peaked at $116K in Q4 2013. 94 funds tracked by Wall St. Rank hold VIVS as of Q1 2014.

Cupps Capital Management reported no remaining VivoSim Labs position as of Q1 2014 after selling out during the quarter.
Cupps Capital Management sold 44 VivoSim Labs shares in Q1 2014, an estimated $116K.
Cupps Capital Management first reported a position in VivoSim Labs in Q4 2013 and held it in 1 quarter.
Cupps Capital Management's VivoSim Labs position peaked at $116K in Q4 2013.
94 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2014.

Based on Cupps Capital Management's 13F filing for Q1 2014, filed 12 May 2014.